Skip to main
University-wide Navigation

While attending the Alzheimer's Disease / Parkinson's Disease (AD/PD) 2022 Conference in Barcelona, Spain, Dr. Florin Despa gave a talk on our lab's work, which was entitled "The hypothesis of diabetes-associated cerebrovascular amylin deposits blocking β amyloid elimination from the Alzheimer’s disease brain."

Dr. Despa was also interviewed on what could underlie the increased risk of individuals with type-2 diabetes developing dementia. In another interview, he also discusses how hyperamylinemia impairs Aβ removal in the brains of individuals with Alzheimer's disease.

You can view Dr. Florin Despa's interviews below or by visiting this link.

 

Hyperamylinemia in early type-2 diabetes blocks Aβ elimination in the Alzheimer’s disease brain

What underlies the increased risk of dementia in patients with type 2 diabetes?